Results 111 to 120 of about 13,874 (194)

Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis

Clinical Transplantation and Research
Background : Valganciclovir (ValG) is the most widely used drug for cytomegalovirus (CMV) prophylaxis in kidney transplant recipients (KTRs). However, it is associated with dose-limiting side effects and considerable costs.
Leonardo Januário Campos Cardoso, Kleuber Arias Meireles Martins, Paulo Vitor Marques, Ivan Petterson Santana Teixeira, Ester Magalhães, Juan Lima Minkauskas, Isabela Coutinho Faria, Filipe Melo Ribeiro   +7 more
doaj   +1 more source

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

Infection and Drug Resistance, 2019
Guy El Helou,1,2 Raymund R Razonable1,21Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA; 2William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USAAbstract ...
El Helou G, Razonable RR
doaj  

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial. [PDF]

EClinicalMedicine
Jacobs TG, Mumbiro V, Tembo J, Egbe FN, Moraleda C, Beca LSDAB, Passanduca A, Kakooza L, Chitsamatanga M, Nduna B, Bramugy J, Tagarro A, Chhaganlal KD, Mutesi S, Mark NL, Bwakura-Dangarembizi M, Namuzizya N, Ballesteros A, Dominguez-Rodríguez S, Colbers A, Sacarlal J, Nalwanga D, Mujuru HA, Chabala C, Madrid L, Buck WC, Musiime V, Bates M, Rojo P, Burger DM, EMPIRICAL Clinical Trial Group.   +30 more
europepmc   +1 more source

Maribavir for cytomegalovirus retinitis: A case series and review of the literature. [PDF]

AJO Int
Shughoury A, Emami S, Kaisari E, Kharouba R, Thomas AS, Goldstein DA, Janetos TM.   +6 more
europepmc   +1 more source

Beyond valganciclovir: A meta-analysis of letermovir's safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation. [PDF]

BMC Infect Dis
Usman M, Yuan Z, Yu H, Chen X, Tang Z, Liu C, Li Z, He W, Xu K.   +8 more
europepmc   +1 more source

Response to the Letter by Sah and Kumbhalwar on "Population Pharmacokinetics and Dose Optimization of Valganciclovir and Ganciclovir in Lung Transplant Recipients". [PDF]

Med Princ Pract
Dvořáčková E, Michaličková D.
europepmc   +1 more source

Cytomegalovirus retinitis in a seronegative patient with systemic lupus erythematosus on immunosuppressive therapy [PDF]

, 2011
Aditya Kelkar, Jai Kelkar, Shreekant Kelkar, Shilpa Bhirud, Jyotirmoy Biswas   +4 more
core   +1 more source

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature [PDF]

, 2016

core   +1 more source

Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients. [PDF]

Clin Infect Dis
Limaye AP, Crespo M, Kamar N, Humar A, Carroll RP, Pereira MR, Broyde N, Wang W, Haber B.   +8 more
europepmc   +1 more source

Chronic Gastric Ulceration Due to Cytomegalovirus in Immunocompetent Adults - A Case Report and Systematic Review. [PDF]

Rev Med Virol
Al-Timimi Z, Geddes A, Lawrence R.
europepmc   +1 more source